Trends in mortality for gastric cancer from 2011 to 2020 with prediction to 2030: a Bayesian age-period-cohort analysis

IF 7.6 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES The Lancet Regional Health: Western Pacific Pub Date : 2025-02-01 DOI:10.1016/j.lanwpc.2024.101298
Zhe Liu, Peng Yin
{"title":"Trends in mortality for gastric cancer from 2011 to 2020 with prediction to 2030: a Bayesian age-period-cohort analysis","authors":"Zhe Liu,&nbsp;Peng Yin","doi":"10.1016/j.lanwpc.2024.101298","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Gastric cancer was the 3rd most common cause of cancer deaths, accounting for 11.3% of all cancer deaths in China in 2018. The study aims to analyze trends in gastric cancer mortality in China from 2011 to 2020, and predict the future burden of gastric cancer from 2021 to 2030.</div></div><div><h3>Methods</h3><div>Relevant data on gastric cancer were obtained from the National Mortality Surveillance System, which is available from the Chinese Center for Disease Control and Prevention. All deaths with underlying cause of death as gastric cancer (International Classification of Diseases-10 code: C16) were included. We analyzed the numbers and age-standardized mortality rates (ASMR) for gastric cancer by sex and urbanicity in China during 2011-2020. A Bayesian age-period-cohort (BAPC) prediction model was used to predict gastric cancer mortality by sex and urbanicity in China from 2021 to 2030. The gastric cancer death data from 2011 to 2020 were categorized into five-year age groups, from 0-4 to 80+. Population data for 2011-2020 were obtained from the National Bureau of Statistics. Projected population data for 2021-2030 were based on estimates derived from 2011-2020 population. The standard population for calculating ASMR was derived from the China Census in 2020.</div></div><div><h3>Findings</h3><div>In 2020, the ASMR for gastric cancer was 22.24/100,000, accounting for 291.20 thousand deaths in China, including 199.66 thousand males and 91.53 thousand females. The ASMR in males (32.57/100,000) was higher than that in females (13.09/100,000). From 2011 to 2020, the number of gastric cancer deaths in China showed a gradual downward trend, with a notable decline in the ASMR. From 2021 to 2030, the ASMR for gastric cancer in China is expected to continue declining. In 2030, It is anticipated that the ASMR of gastric cancer in China will be 11.68/100,000, resulting in an estimated 218.93 thousand deaths. The ASMR for males is projected to decrease to 17.78/100,000, representing a 45.4% reduction from 2020. For females, the ASMR will decrease to 6.81/100,000 corresponding to a significant reduction of 48.0% from the 2020. In 2030, the projected ASMR for gastric cancer is 11.67/100,000 in urban areas and 12.04/100,000 in rural areas, accounting for 111.90 thousand and 125.92 thousand deaths, respectively. Compared to 2020, the ASMR for gastric cancer in 2030 shows a 38.7% and 50.9% reduction in urban and rural areas, respectively.</div></div><div><h3>Interpretation</h3><div>From 2011 to 2020, both the number of deaths and the ASMR of gastric cancer in China gradually declined. The number of gastric cancer deaths in China is projected to continue declining through 2030. The findings indicate that the preventive and control measures for gastric cancer are effective and may provide useful reference for development of preventive and control strategies for other major cancers in China.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"55 ","pages":"Article 101298"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Regional Health: Western Pacific","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266660652400292X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Gastric cancer was the 3rd most common cause of cancer deaths, accounting for 11.3% of all cancer deaths in China in 2018. The study aims to analyze trends in gastric cancer mortality in China from 2011 to 2020, and predict the future burden of gastric cancer from 2021 to 2030.

Methods

Relevant data on gastric cancer were obtained from the National Mortality Surveillance System, which is available from the Chinese Center for Disease Control and Prevention. All deaths with underlying cause of death as gastric cancer (International Classification of Diseases-10 code: C16) were included. We analyzed the numbers and age-standardized mortality rates (ASMR) for gastric cancer by sex and urbanicity in China during 2011-2020. A Bayesian age-period-cohort (BAPC) prediction model was used to predict gastric cancer mortality by sex and urbanicity in China from 2021 to 2030. The gastric cancer death data from 2011 to 2020 were categorized into five-year age groups, from 0-4 to 80+. Population data for 2011-2020 were obtained from the National Bureau of Statistics. Projected population data for 2021-2030 were based on estimates derived from 2011-2020 population. The standard population for calculating ASMR was derived from the China Census in 2020.

Findings

In 2020, the ASMR for gastric cancer was 22.24/100,000, accounting for 291.20 thousand deaths in China, including 199.66 thousand males and 91.53 thousand females. The ASMR in males (32.57/100,000) was higher than that in females (13.09/100,000). From 2011 to 2020, the number of gastric cancer deaths in China showed a gradual downward trend, with a notable decline in the ASMR. From 2021 to 2030, the ASMR for gastric cancer in China is expected to continue declining. In 2030, It is anticipated that the ASMR of gastric cancer in China will be 11.68/100,000, resulting in an estimated 218.93 thousand deaths. The ASMR for males is projected to decrease to 17.78/100,000, representing a 45.4% reduction from 2020. For females, the ASMR will decrease to 6.81/100,000 corresponding to a significant reduction of 48.0% from the 2020. In 2030, the projected ASMR for gastric cancer is 11.67/100,000 in urban areas and 12.04/100,000 in rural areas, accounting for 111.90 thousand and 125.92 thousand deaths, respectively. Compared to 2020, the ASMR for gastric cancer in 2030 shows a 38.7% and 50.9% reduction in urban and rural areas, respectively.

Interpretation

From 2011 to 2020, both the number of deaths and the ASMR of gastric cancer in China gradually declined. The number of gastric cancer deaths in China is projected to continue declining through 2030. The findings indicate that the preventive and control measures for gastric cancer are effective and may provide useful reference for development of preventive and control strategies for other major cancers in China.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
The Lancet Regional Health: Western Pacific
The Lancet Regional Health: Western Pacific Medicine-Pediatrics, Perinatology and Child Health
CiteScore
8.80
自引率
2.80%
发文量
305
审稿时长
11 weeks
期刊介绍: The Lancet Regional Health – Western Pacific, a gold open access journal, is an integral part of The Lancet's global initiative advocating for healthcare quality and access worldwide. It aims to advance clinical practice and health policy in the Western Pacific region, contributing to enhanced health outcomes. The journal publishes high-quality original research shedding light on clinical practice and health policy in the region. It also includes reviews, commentaries, and opinion pieces covering diverse regional health topics, such as infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, aging health, mental health, the health workforce and systems, and health policy.
期刊最新文献
Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling study Strategies for the prevention of ischemic stroke in atrial fibrillation in East Asia: clinical features, changes and challenges Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients Middle-age cerebral small vessel disease and cognitive function in later life: a population-based prospective cohort study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1